FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39537811000001107: Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1772281000001110 Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1772291000001112 Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Is a Rivastigmine 13.3mg/24hours transdermal patches 30 patch true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has AMP Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has specific active ingredient Rivastigmine true Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start